The Glioblastoma Research Organization (GBMRO) will host its second Padel for Brain Cancer event presented by Atria Health Collaborative in partnership with Reserve, the leading luxury lifestyle padel brand. The tournament will kick off Brain Tumor Awareness Month with a competitive bracket tournament on May 11, 2024, from 8:30 a.m. to 6 p.m. at Reserve's state-of-the-art Hudson Yards location in Midtown Manhattan.

Padel for Brain Cancer promises not only an exciting day of competition, but also a collective effort toward impactful progress in brain cancer research funding. Leading our community partners is presenting sponsor, Atria Health Collaborative, a medical collective that brings together scientists, researchers, and doctors to translate science into clinical practice in real time.

The event will feature 32 teams of pairs vying for victory across two brackets. Winners will receive a complimentary scan from our partners at Prenuvo and high-quality padel accessories from TWOTWO Padel. A sunset cocktail hour will follow the tournament, kindly made possible by brand partners like Hampton Water Wine Co.

"We're thrilled to bring our Padel for Brain Cancer event to New York City following its triumphant debut in Miami. With over 130 attendees joining forces, we raised more than $45K for vital brain cancer research," shared Amber Barbach, founder and director of the Glioblastoma Research Organization. "Thanks to our partners at Reserve, we've mobilized the wellness community to advocate for a cause that desperately needs more funding."

Attendees can expect refreshing sips and delectable bites, as well as the chance to win exciting raffle prizes and engage with brand activations from event sponsors such as Drip Hydration, EAROS, Fazit, Fleur Wellness, Love Corn, Matchaful, Miami Beach Bum, Poppi, Prenuvo, Sweet Nothings, The Tox and Vacation® Inc; twentyonegrains will provide a nourishing, gluten-free lunch for our athletes and spectators.

Proceeds from ticket sales will support the GBMRO’s mission to raise awareness and funds for new global, cutting-edge research to find a cure for glioblastoma.